Skip to main content

Animations

MJFF Publications

5621 - 5630 of 8587 Results
Title
Year
  • Year
  • 2023
  • 2005
  • 2015
  • 2020
  • 2016
  • 2019
  • 2016
  • 2020
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.20751
    Best OA location URL:
    Citation Count: 90
  • Summary Details
    RESTRICTED
    Title: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021
    Best OA location URL:
    Citation Count: 73
  • Summary Details
    RESTRICTED
    Title: Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease
    Journal Name: Psychogeriatrics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/psyg.12601
    Best OA location URL:
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: Neuropsychological impairment in prodromal Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    OPEN
    Title: To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/braincomms/fcz016
    Citation Count: 33
  • Summary Details
    OPEN
    Title: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?
    Journal Name: Hippocampus
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hipo.22671
    Citation Count: 158
  • Summary Details
    OPEN
    Title: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-191786
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Pathway‐Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29030
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.